1 year return (CAGR)
13.64%
Hepion Pharmaceuticals Inc Exchange (NASDAQ, USD)
HEPA
0.06
-0.02 (-20.89%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-95.73%
5 year return (CAGR)
-87.06%
10 year return (CAGR)
-79.47%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.64M
Price/Sales
-
Ent value
4.66M
Price/Book
4.41
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-78.90%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.06 |
| Daily high | 0.06 |
| Daily low | 0.06 |
| Daily Volume | 0K |
| All-time high | 3220000.00 |
| 1y analyst estimate | 30.00 |
| Beta | 1.65 |
| EPS (TTM) | -0.20 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| HEPA | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -87.45% | -10.68% |
| Avg time to new high | 221 days | 12 days |
| Max time to new high | 2740 days | 1805 days |
News
